The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling options. Increasing technological advancements have created several opportunities for market expansion in direct-to-consumer (DTC) wellness testing. Many diverse factors are driving continual market growth globally, including an increasing interest in and development of personalized medicine, the prevalence of chronic diseases, and the development of customized testing kits. The cancer and infectious diseases segments are also boosting market growth as the prevalence of these conditions is trending upward.
In addition, people are becoming more proactive about managing their health and seeking personalized insights into their genetic makeup, nutritional needs, and overall well-being. This drives market expansion and creates new opportunities for market convergence, such as the DTC testing market with large eCommerce companies and wearables manufacturers.
This study examines the global DTC wellness testing market and provides an analysis of its drivers and growth opportunities across the different types of tests, samples, and distribution channels. This report will help vendors understand critical trends emerging in various domains.
Scope of Analysis
- This study assesses the global market for DTC wellness tests, including DTC genetic tests (DTC-GTs). Individuals perform these medical tests outside of a laboratory using a kit they have obtained from a manufacturer or an online vendor to conduct the test at home.
- The market has several regional players operating across different countries.
- Market segmentation includes the types of tests and how entities offer them, the type of sample they require, and the distribution channel through which consumers can acquire them.
- The market covers tests for hormones, micronutrients, infectious diseases such as COVID-19 and sexually transmitted infections (STIs), food intolerance, and food sensitivity. The others segment includes cardiac and allergy tests.
- The study covers 4 different forms of offer. The test panel offers multiple tests in a single package or panel. With test strips, users apply the sample and observe the results. Digital monitoring instruments are electronic devices that allow users to monitor their health or well-being parameters continuously or periodically. Offers that do not fit into the above categories fall within the domain of “others,” such as health-tracking apps, virtual health coaching, or genetic counseling services.
- The study assesses different sample types, such as blood, urine, and saliva. The others category encompasses other sample types, including hair, feces, or other less common biological samples.
- Finally, the study analyzes the distribution channels of these tests. Online sales involve selling DTC wellness products and services over the internet directly through online platforms, company websites, mobile applications, and other digital channels. Over the counter (OTC) refers to the sale of DTC wellness products and services through physical points of sale, such as pharmacies, supermarkets, and other retail stores, without requiring a medical prescription.
Segmentation
DTC Wellness Testing
Test Type
- Hormones
- Micronutrients
- Infectious Disease
- Food Intolerance
- Food Sensitivity
- Others
Offering Type
- Test Panel
- Test Strips
- Digital Monitoring Instruments
- Others
Sample Type
- Blood
- Urine
- Saliva
- Others
Distribution Channel
- Online
- OTC
Competitive Environment
| Number of Competitors | 100 with revenue greater than $1 million |
| Competitive Factors | Cost, technology, reliability, accuracy, pricing, brand value, ease of collection and interpretation, telehealth integration, test portfolio variety, and partner relationships |
| Leading Competitors | LabCorp, Quest Diagnostics, 23andMe, Everlywell, Lets Get Checked, and Myriad Genetics |
| Other Notable Competitors | Cue, Color Genomics, CircleDNA, myLAB Box, Ro, Tomorrow’s Health, Viome Life Sciences, Nebula Genomics, MeuDNA, and Medichecks |
| Distribution Structure | Direct sales through online channels on their websites or those of their associated companies or OTC in places such as supermarkets and pharmacies |
| Notable Acquisitions and Mergers | In March 2022, Ro (Modern Fertility) acquired Dadi, a sperm testing, storage, and analysis company In February 2022, Kindbody acquired Vios Fertility Institute In August 2021, Ancestry acquired the prominent French genealogy firm, Geneanet |
Companies to Watch
- CircleDNA
Medicheks
- Vitagene
- Companies to Watch
- Veritas Genetics
- Thriva.
- Mapmygene
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Direct-to-Consumer (DTC) Wellness Testing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Competitive Landscape
COVID-19 Pandemic Impact
Growth Drivers
Growth Restraints
Market Overview
Growth Environment
Growth Environment (continued)
Growth Environment (continued)
Growth Environment (continued)
State of the Industry—Geographic Highlights
State of the Industry—Geographic Highlights (continued)
Trend 1: The Integration of DTC Wellness Testing with Telehealth Services
Trend 2: The Expansion of Clinical Laboratories across the DTC Testing Frontier
Trend 3: Genetic Testing and Personalized Risk Assessments for Cardiovascular and Metabolic Conditions
Trend 4: The Development and Expansion of Nutrigenomics Offering
Trend 5: DTC Tests for Multi-pathogenic STIs
Competitive Environment
Companies to Watch
Companies to Watch (continued)
Business Models
Operating Models of Companies
Customer Acquisition Models
Regulatory Landscape
Regulatory Landscape (continued)
Regulatory Landscape (continued)
Growth Opportunity 1: Contract Reference Labs for Sample Collection and Analysis
Growth Opportunity 1: Contract Reference Labs for Sample Collection and Analysis (continued)
Growth Opportunity 2: Partnerships between DTC Wellness Testing Companies and Insurance Providers
Growth Opportunity 2: Partnerships between DTC Wellness Testing Companies and Insurance Providers (continued)
Growth Opportunity 3: Technological Evolution of Molecular Diagnostics for DTC Wellness Tests
Growth Opportunity 3: Technological Evolution of Molecular Diagnostics for DTC Wellness Tests (continued)
Growth Opportunity 4: Convergence of DTC Wellness Tests and Consumer Wearables
Growth Opportunity 4: Convergence of DTC Wellness Tests and Consumer Wearables (continued)
List of Exhibits
Legal Disclaimer
- DTC Wellness Testing: Growth Drivers, Global, 2024–2028
- DTC Wellness Testing: Growth Restraints, Global, 2024–2028
- DTC Wellness Testing: Total Addressable Market, Global, 2023 and 2028
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Lucila Martin |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Wellness Testing Analysis |
| Keyword 2 | Wellness Industry Trends |
| Keyword 3 | Healthcare Testing Innovations |
| List of Charts and Figures | DTC Wellness Testing: Growth Drivers, Global, 2024–2028~ DTC Wellness Testing: Growth Restraints, Global, 2024–2028~ DTC Wellness Testing: Total Addressable Market, Global, 2023 and 2028~ |
| Podcast | No |
| WIP Number | K9D2-01-00-00-00 |
Direct-to-Consumer Wellness Testing Growth Opportunities
Telehealth Integration to Reveal the Potential of DTC Genetic Tests and Boost Their Expansion
17-Jan-2024
Global
Market Research




